Description: Quris AI is tackling the most impactful AI challenge of our time: Predicting which drug candidates will safely work in humans. Quris’s machine-learning bio-platform predicts which drug candidates will safely work in humans.
Quris' Bio-AI Clinical Prediction Platform better predicts which drug candidates will safely work in humans, avoiding tremendous costs of failed clinical trials.
We are led by a team of top scientists and strategic investors and are actively preparing for clinical testing with our first AI-based drug.
First AI Clinical Prediction Platform Drug development is expensive, with 89% of drugs ultimately failing in clinical trials. Quris aims to address the trillion-dollar challenge that other unicorn AI-Pharma companies have not: Predicting which drug candidate will safely work in humans. More…
InSphero | 3D In Vitro Models for Non-animal Drug Testing
AI in Pharma: Discovery | October 4th | Boston, MA
InSphero | 3D In Vitro Models for Non-animal Drug Testing
Home | Veblen
InSphero | 3D In Vitro Models for Non-animal Drug Testing
InSphero | 3D In Vitro Models for Non-animal Drug Testing
InSphero | 3D In Vitro Models for Non-animal Drug Testing
Projects | max-burger 2